Tumor cells release circulating tumor DNA (ctDNA) into the bloodstream, which is collected through liquid biopsies. ctDNA analysis provides abundant information about tumors, but can be limited by the rarity of ctDNA in the total circulating DNA fragment pool. To overcome this challenge, researchers turn to advanced next generation sequencing (NGS) technology.

Download this ebook from The Scientist's Creative Services Team and Twist Bioscience to learn about

  • Detecting ctDNA in liquid biopsies through NGS
  • The challenges of analyzing ctDNA in patient samples and the tools to overcome them
  • ctDNA detection success stories

Sponsored by